These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10492770)

  • 1. Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases.
    Thakur CP; Singh RK; Hassan SM; Kumar R; Narain S; Kumar A
    Trans R Soc Trop Med Hyg; 1999; 93(3):319-23. PubMed ID: 10492770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on amphotericin B treatment of kala-azar given in a rural set up in Bihar, India.
    Thakur CP; Ahmed S
    Indian J Med Res; 2001 Jan; 113():14-8. PubMed ID: 11280166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study.
    Mondal D; Alvar J; Hasnain MG; Hossain MS; Ghosh D; Huda MM; Nabi SG; Sundar S; Matlashewski G; Arana B
    Lancet Glob Health; 2014 Jan; 2(1):e51-7. PubMed ID: 25104636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.
    Sundar S; Sinha PK; Rai M; Verma DK; Nawin K; Alam S; Chakravarty J; Vaillant M; Verma N; Pandey K; Kumari P; Lal CS; Arora R; Sharma B; Ellis S; Strub-Wourgaft N; Balasegaram M; Olliaro P; Das P; Modabber F
    Lancet; 2011 Feb; 377(9764):477-86. PubMed ID: 21255828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized comparison of classical mode of administration of amphotericin B with its newer modes of administration in kala-azar.
    Thakur CP; Kumar P; Kumar N; Singh GN; Singh AK; Narain S
    J Assoc Physicians India; 1998 Sep; 46(9):779-83. PubMed ID: 11229246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex.
    Sundar S; Murray HW
    J Infect Dis; 1996 Mar; 173(3):762-5. PubMed ID: 8627049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin B in resistant kala-azar in Bihar.
    Thakur CP; Sinha GP; Pandey AK; Barat D; Sinha PK
    Natl Med J India; 1993; 6(2):57-60. PubMed ID: 8477209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis?
    Thakur CP; Sinha GP; Barat D; Singh RK
    Ann Trop Med Parasitol; 1994 Aug; 88(4):365-70. PubMed ID: 7979623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis.
    Sundar S; Gupta LB; Rastogi V; Agrawal G; Murray HW
    Trans R Soc Trop Med Hyg; 2000; 94(2):200-4. PubMed ID: 10897369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of visceral leishmaniasis with amphotericin B colloidal dispersion.
    Berman J; Dietze R
    Chemotherapy; 1999 Jun; 45 Suppl 1():54-66. PubMed ID: 10394022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose liposomal amphotericin B for visceral leishmaniasis in India.
    Sundar S; Chakravarty J; Agarwal D; Rai M; Murray HW
    N Engl J Med; 2010 Feb; 362(6):504-12. PubMed ID: 20147716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial.
    Sundar S; Agrawal G; Rai M; Makharia MK; Murray HW
    BMJ; 2001 Aug; 323(7310):419-22. PubMed ID: 11520836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence.
    Ritmeijer K; ter Horst R; Chane S; Aderie EM; Piening T; Collin SM; Davidson RN
    Clin Infect Dis; 2011 Dec; 53(12):e152-8. PubMed ID: 22016502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis.
    Bodhe PV; Kotwani RN; Kirodian BG; Pathare AV; Pandey AK; Thakur CP; Kshirsagar NA
    Trans R Soc Trop Med Hyg; 1999; 93(3):314-8. PubMed ID: 10492769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
    Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK
    Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of amphotericin B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent adult patients.
    Gaeta GB; Maisto A; Di Caprio D; Scalone A; Pasquale G; Felaco FM; Galante D; Gradoni L
    Scand J Infect Dis; 2000; 32(6):675-7. PubMed ID: 11200380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis.
    Thakur CP; Narain S; Kumar N; Hassan SM; Jha DK; Kumar A
    Ann Trop Med Parasitol; 1997 Sep; 91(6):611-6. PubMed ID: 9425363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable paromomycin for Visceral leishmaniasis in India.
    Sundar S; Jha TK; Thakur CP; Sinha PK; Bhattacharya SK
    N Engl J Med; 2007 Jun; 356(25):2571-81. PubMed ID: 17582067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex.
    Sundar S; Goyal AK; More DK; Singh MK; Murray HW
    Ann Trop Med Parasitol; 1998 Oct; 92(7):755-64. PubMed ID: 9924533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions.
    Sundar S; Chakravarty J; Rai VK; Agrawal N; Singh SP; Chauhan V; Murray HW
    Clin Infect Dis; 2007 Sep; 45(5):556-61. PubMed ID: 17682988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.